Pub Date : 2024-12-01DOI: 10.1016/j.igie.2024.08.004
Karsten Büringer Dr med , Stefano Fusco Dr med , Dörte Wichmann PD Dr med , Ulrike Schempf Dr med , Pavlos Missios Dr rer med , Christoph Stein-Thöringer Prof Dr med , Dominik Zinsser Dr med , Nisar P. Malek Prof Dr med , Christoph R. Werner PD Dr med
{"title":"Transgastric biliary drainage through a biliodigestive efferent loop using a lumen-apposing metal stent","authors":"Karsten Büringer Dr med , Stefano Fusco Dr med , Dörte Wichmann PD Dr med , Ulrike Schempf Dr med , Pavlos Missios Dr rer med , Christoph Stein-Thöringer Prof Dr med , Dominik Zinsser Dr med , Nisar P. Malek Prof Dr med , Christoph R. Werner PD Dr med","doi":"10.1016/j.igie.2024.08.004","DOIUrl":"10.1016/j.igie.2024.08.004","url":null,"abstract":"","PeriodicalId":100652,"journal":{"name":"iGIE","volume":"3 4","pages":"Pages 473-474"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143139901","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-12-01DOI: 10.1016/j.igie.2024.10.001
Rahul Ramakrishnan BS , Kevin Kuang BA , Vijay Rajput MD , Mark Benson MD , Sachin Mohan MD, PhD
Background and Aims
Esophageal varices (EVs) result from portal hypertension in decompensated liver disease secondary to liver cirrhosis. Diagnosis and grading is done using EGD and mucosal examination. However, interobserver differences may occur when analyzing EGD results. Recent application of artificial intelligence (AI) algorithms yielded mixed results for varices detection and bleeding risk estimation. The capabilities of AI in the detection and grading of EVs need to be evaluated.
Methods
A systematic review was conducted with Preferred Reporting Items for Systematic reviews and Meta-Analyses guidelines. PubMed, EMBASE, and MEDLINE were searched from January 1956 to July 2023. Data were manually identified and extracted by reviewers, assessing outcomes of AI tools used, EV detection accuracies, and bleeding risk prediction accuracies. Average accuracies were derived from result sections or manual calculations.
Results
Sixteen studies with 26,170 patients and 19 AI systems and algorithms were included after a review of 1670 studies. The most common AI systems were artificial neural network and random forest. The categorical boosting machine learning (ML) algorithm was most accurate for prediction of bleeding (100%), whereas the radiomic model ML tool was the least accurate for EV detection (49%). Overall, AI had an average EV detection accuracy of 78.67% and variceal bleed accuracy of 83.2%.
Conclusions
AI could provide an accessible interface for EV prediction and estimation of bleeding risk. Limitations include the dependence on a single dataset for efficacy, assessment with specific AI tools, and potential overinterpretation of broad geographic variances. Newer algorithms should have larger datasets with reproducible validity to strengthen the predictive value in clinical practice.
{"title":"Esophageal varices detection and bleeding risk assessment with artificial intelligence: a systematic review","authors":"Rahul Ramakrishnan BS , Kevin Kuang BA , Vijay Rajput MD , Mark Benson MD , Sachin Mohan MD, PhD","doi":"10.1016/j.igie.2024.10.001","DOIUrl":"10.1016/j.igie.2024.10.001","url":null,"abstract":"<div><h3>Background and Aims</h3><div>Esophageal varices (EVs) result from portal hypertension in decompensated liver disease secondary to liver cirrhosis. Diagnosis and grading is done using EGD and mucosal examination. However, interobserver differences may occur when analyzing EGD results. Recent application of artificial intelligence (AI) algorithms yielded mixed results for varices detection and bleeding risk estimation. The capabilities of AI in the detection and grading of EVs need to be evaluated.</div></div><div><h3>Methods</h3><div>A systematic review was conducted with Preferred Reporting Items for Systematic reviews and Meta-Analyses guidelines. PubMed, EMBASE, and MEDLINE were searched from January 1956 to July 2023. Data were manually identified and extracted by reviewers, assessing outcomes of AI tools used, EV detection accuracies, and bleeding risk prediction accuracies. Average accuracies were derived from result sections or manual calculations.</div></div><div><h3>Results</h3><div>Sixteen studies with 26,170 patients and 19 AI systems and algorithms were included after a review of 1670 studies. The most common AI systems were artificial neural network and random forest. The categorical boosting machine learning (ML) algorithm was most accurate for prediction of bleeding (100%), whereas the radiomic model ML tool was the least accurate for EV detection (49%). Overall, AI had an average EV detection accuracy of 78.67% and variceal bleed accuracy of 83.2%.</div></div><div><h3>Conclusions</h3><div>AI could provide an accessible interface for EV prediction and estimation of bleeding risk. Limitations include the dependence on a single dataset for efficacy, assessment with specific AI tools, and potential overinterpretation of broad geographic variances. Newer algorithms should have larger datasets with reproducible validity to strengthen the predictive value in clinical practice.</div></div>","PeriodicalId":100652,"journal":{"name":"iGIE","volume":"3 4","pages":"Pages 478-486"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143140066","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-12-01DOI: 10.1016/j.igie.2024.08.003
Utku Erden BSc , Mark A. Gromski MD , Suvranu De ScD , Doga Demirel PhD
Background and Aims
Obesity is a global health concern. Bariatric surgery offers reliably effective and durable weight loss and improvements of other comorbid conditions. However, the accessibility of bariatric surgery remains limited. Minimally invasive techniques, including endoscopic sleeve gastroplasty (ESG), have emerged to bridge this gap. To effectively complete the ESG procedure, one requires skill in multiple complex interventional endoscopic maneuvers. This requisite expertise poses challenges for training in this burgeoning field.
Methods
We designed the virtual bariatric endoscopic (ViBE) simulator software to mimic the ESG procedure accurately. The ViBE simulator features a detailed simulation of an endoscope equipped with an endoscopic suturing system and a high-resolution stomach, enhancing the visualization of procedural details. Furthermore, the simulator incorporates performance metrics using a reverse scoring system to evaluate users’ proficiency in tasks such as argon plasma coagulation (APC) marking, suturing, and cinching. To validate the simulator, we conducted a study involving experts and novices at the Indiana University School of Medicine, where participants engaged with the simulation environment in a series of training tasks.
Results
Twelve participants, comprising 5 experts and 7 novices, were asked to complete a post-training questionnaire featuring 7 items, rating each on a Likert scale. The APC task realism received the highest score, averaging 3.83. The usefulness of improving endoscopic technical skills averaged 3.08, with the realism of cinching the knot and suturing tasks receiving scores of 3.17 and 3.25, respectively, suggesting a generally positive reception. Automated performance metrics indicated that, on average, experts outperformed novices by 10.83 points.
Conclusions
The ViBE simulation strives to replicate the steps of the ESG within a virtual environment. Our primary objective in developing this simulator was to enhance the learning curve for endoscopic suturing and ESG techniques, thereby safely extending these skills to a broader patient base.
{"title":"Preliminary validation of the virtual bariatric endoscopic simulator","authors":"Utku Erden BSc , Mark A. Gromski MD , Suvranu De ScD , Doga Demirel PhD","doi":"10.1016/j.igie.2024.08.003","DOIUrl":"10.1016/j.igie.2024.08.003","url":null,"abstract":"<div><h3>Background and Aims</h3><div>Obesity is a global health concern. Bariatric surgery offers reliably effective and durable weight loss and improvements of other comorbid conditions. However, the accessibility of bariatric surgery remains limited. Minimally invasive techniques, including endoscopic sleeve gastroplasty (ESG), have emerged to bridge this gap. To effectively complete the ESG procedure, one requires skill in multiple complex interventional endoscopic maneuvers. This requisite expertise poses challenges for training in this burgeoning field.</div></div><div><h3>Methods</h3><div>We designed the virtual bariatric endoscopic (ViBE) simulator software to mimic the ESG procedure accurately. The ViBE simulator features a detailed simulation of an endoscope equipped with an endoscopic suturing system and a high-resolution stomach, enhancing the visualization of procedural details. Furthermore, the simulator incorporates performance metrics using a reverse scoring system to evaluate users’ proficiency in tasks such as argon plasma coagulation (APC) marking, suturing, and cinching. To validate the simulator, we conducted a study involving experts and novices at the Indiana University School of Medicine, where participants engaged with the simulation environment in a series of training tasks.</div></div><div><h3>Results</h3><div>Twelve participants, comprising 5 experts and 7 novices, were asked to complete a post-training questionnaire featuring 7 items, rating each on a Likert scale. The APC task realism received the highest score, averaging 3.83. The usefulness of improving endoscopic technical skills averaged 3.08, with the realism of cinching the knot and suturing tasks receiving scores of 3.17 and 3.25, respectively, suggesting a generally positive reception. Automated performance metrics indicated that, on average, experts outperformed novices by 10.83 points.</div></div><div><h3>Conclusions</h3><div>The ViBE simulation strives to replicate the steps of the ESG within a virtual environment. Our primary objective in developing this simulator was to enhance the learning curve for endoscopic suturing and ESG techniques, thereby safely extending these skills to a broader patient base.</div></div>","PeriodicalId":100652,"journal":{"name":"iGIE","volume":"3 4","pages":"Pages 453-462"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11720207/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142973540","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-12-01DOI: 10.1016/j.igie.2024.09.004
Alyssa Y. Choi MD , Peter H. Nguyen MD , Jaehyun Kim MD , Julie Yang MD , Sherif A. Andrawes MD , Jean Chalhoub MD , Anastasia Chahine MD , Andrew Q. Giap MD , David P. Lee MD , Kenneth H. Park MD , Quin Y. Liu MD , Srinivas Gaddam MD , Kendrick Che DO , Michael Lajin MD , Wasseem Skef MD , Amirali Tavangar MD , John J. Kim MD , Jason B. Samarasena MD, MBA
Background and Aims
A novel gastroduodenal full-thickness resection device system was developed for resection of upper GI tract lesions. In this study, we evaluated the efficacy and safety of the gastroduodenal full-thickness resection device system.
Methods
Consecutive patients who received endoscopic resection of upper GI tract lesions from June 2020 to August 2022 using a gastroduodenal full-thickness resection device were evaluated from 8 U.S. centers. Primary endpoints were technical success and R0 resection. Secondary endpoints were en bloc resection, residual lesions at follow-up endoscopy, and immediate or delayed adverse events.
Results
Forty-four patients (mean age, 60.9 ± 15.8 years) received 45 resections for gastric (35, 80%) and duodenal (9, 20%) lesions. Thirty-four lesions (77%) were subepithelial and 10 (23%) were epithelial lesions. Technical success and en bloc resection were achieved in 43 (96%) and 41 (91%) patients, respectively. Furthermore, R0 resection was achieved in 32 patients (71%), including 24 of 35 (69%) with neoplastic lesions. Pathologic diagnosis included neuroendocrine tumor in 14 patients (32%), GI stromal tumor in 10 (23%), and gastric cancer or high-grade dysplasia in 7 (16%). Minor immediate and delayed bleeding occurred in 17 (38%) and 2 (4%) patients, respectively. One patient had delayed perforation, managed conservatively. On follow-up, 19 of 21 patients (90%) had no residual lesion.
Conclusions
In this multicenter series, the gastroduodenal full-thickness resection device demonstrated high rates of technical success and acceptable rate of R0 resection. Immediate minor bleeding was common, whereas serious adverse events were rare. This gastroduodenal full-thickness resection device should be considered in patients with gastroduodenal subepithelial lesions as an alternative to long-term surveillance.
{"title":"Clinical safety of a novel over-the-scope gastroduodenal full-thickness resection device for the treatment of upper GI tract lesions: a multicenter experience","authors":"Alyssa Y. Choi MD , Peter H. Nguyen MD , Jaehyun Kim MD , Julie Yang MD , Sherif A. Andrawes MD , Jean Chalhoub MD , Anastasia Chahine MD , Andrew Q. Giap MD , David P. Lee MD , Kenneth H. Park MD , Quin Y. Liu MD , Srinivas Gaddam MD , Kendrick Che DO , Michael Lajin MD , Wasseem Skef MD , Amirali Tavangar MD , John J. Kim MD , Jason B. Samarasena MD, MBA","doi":"10.1016/j.igie.2024.09.004","DOIUrl":"10.1016/j.igie.2024.09.004","url":null,"abstract":"<div><h3>Background and Aims</h3><div>A novel gastroduodenal full-thickness resection device system was developed for resection of upper GI tract lesions. In this study, we evaluated the efficacy and safety of the gastroduodenal full-thickness resection device system.</div></div><div><h3>Methods</h3><div>Consecutive patients who received endoscopic resection of upper GI tract lesions from June 2020 to August 2022 using a gastroduodenal full-thickness resection device were evaluated from 8 U.S. centers. Primary endpoints were technical success and R0 resection. Secondary endpoints were en bloc resection, residual lesions at follow-up endoscopy, and immediate or delayed adverse events.</div></div><div><h3>Results</h3><div>Forty-four patients (mean age, 60.9 ± 15.8 years) received 45 resections for gastric (35, 80%) and duodenal (9, 20%) lesions. Thirty-four lesions (77%) were subepithelial and 10 (23%) were epithelial lesions. Technical success and en bloc resection were achieved in 43 (96%) and 41 (91%) patients, respectively. Furthermore, R0 resection was achieved in 32 patients (71%), including 24 of 35 (69%) with neoplastic lesions. Pathologic diagnosis included neuroendocrine tumor in 14 patients (32%), GI stromal tumor in 10 (23%), and gastric cancer or high-grade dysplasia in 7 (16%). Minor immediate and delayed bleeding occurred in 17 (38%) and 2 (4%) patients, respectively. One patient had delayed perforation, managed conservatively. On follow-up, 19 of 21 patients (90%) had no residual lesion.</div></div><div><h3>Conclusions</h3><div>In this multicenter series, the gastroduodenal full-thickness resection device demonstrated high rates of technical success and acceptable rate of R0 resection. Immediate minor bleeding was common, whereas serious adverse events were rare. This gastroduodenal full-thickness resection device should be considered in patients with gastroduodenal subepithelial lesions as an alternative to long-term surveillance.</div></div>","PeriodicalId":100652,"journal":{"name":"iGIE","volume":"3 4","pages":"Pages 490-500"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143139959","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-12-01DOI: 10.1016/j.igie.2024.10.002
Dennis Yang MD , Amit Bhatt MD , Maham Hayat MD , Muhammad K. Hasan MD , Hiroyuki Aihara MD, PhD
Background and Aims
Delayed bleeding (DB) is a common adverse event after endoscopic submucosal dissection (ESD). We evaluated a novel hemostatic powder (UI-EWD, Nexpowder; Medtronic, Minneapolis, Minn, USA) to prevent DB after ESD.
Methods
This was a multicenter retrospective analysis of ESDs performed between January 2023 and March 2024 in which UI-EWD was applied to prevent DB. Cases in which endoscopic closure of the post-ESD mucosal defect was performed were excluded. DB was defined as a bleeding event requiring hospitalization, blood transfusion, or any intervention within 30 days after the procedure. Technical success of UI-EWD was defined as successful delivery and application of the hemostatic powder over the entire mucosal defect.
Results
Eighty-three patients (median age, 66 years) underwent ESD in the esophagus (n = 18), stomach (n = 15), colon (n = 38), and rectum (n = 12). The median lesion size was 50 mm (interquartile range, 41-70 mm). UI-EWD was successfully applied in all defects, although in 2 cases (2.4%) a second delivery catheter had to be used to complete the procedure. DB occurred in 3 patients (3.6%): 2 after gastric ESD and 1 after colonic ESD within 24 hours of the index procedure. None required intervention on repeat endoscopy. There were no cases of perforation. En bloc and R0 resection rates were 96.2% and 88.7%, respectively.
Conclusions
UI-EWD can be easily applied to mucosal defects after ESD throughout the GI tract. Initial data from this multicenter study demonstrate that the use of UI-EWD was associated with a relatively low rate of DB after ESD. Additional comparative studies are needed to corroborate these preliminary findings.
{"title":"Novel hemostatic adhesive powder to prevent delayed bleeding after endoscopic submucosal dissection in the GI tract: first U.S. multicenter experience","authors":"Dennis Yang MD , Amit Bhatt MD , Maham Hayat MD , Muhammad K. Hasan MD , Hiroyuki Aihara MD, PhD","doi":"10.1016/j.igie.2024.10.002","DOIUrl":"10.1016/j.igie.2024.10.002","url":null,"abstract":"<div><h3>Background and Aims</h3><div>Delayed bleeding (DB) is a common adverse event after endoscopic submucosal dissection (ESD). We evaluated a novel hemostatic powder (UI-EWD, Nexpowder; Medtronic, Minneapolis, Minn, USA) to prevent DB after ESD.</div></div><div><h3>Methods</h3><div>This was a multicenter retrospective analysis of ESDs performed between January 2023 and March 2024 in which UI-EWD was applied to prevent DB. Cases in which endoscopic closure of the post-ESD mucosal defect was performed were excluded. DB was defined as a bleeding event requiring hospitalization, blood transfusion, or any intervention within 30 days after the procedure. Technical success of UI-EWD was defined as successful delivery and application of the hemostatic powder over the entire mucosal defect.</div></div><div><h3>Results</h3><div>Eighty-three patients (median age, 66 years) underwent ESD in the esophagus (n = 18), stomach (n = 15), colon (n = 38), and rectum (n = 12). The median lesion size was 50 mm (interquartile range, 41-70 mm). UI-EWD was successfully applied in all defects, although in 2 cases (2.4%) a second delivery catheter had to be used to complete the procedure. DB occurred in 3 patients (3.6%): 2 after gastric ESD and 1 after colonic ESD within 24 hours of the index procedure. None required intervention on repeat endoscopy. There were no cases of perforation. En bloc and R0 resection rates were 96.2% and 88.7%, respectively.</div></div><div><h3>Conclusions</h3><div>UI-EWD can be easily applied to mucosal defects after ESD throughout the GI tract. Initial data from this multicenter study demonstrate that the use of UI-EWD was associated with a relatively low rate of DB after ESD. Additional comparative studies are needed to corroborate these preliminary findings.</div></div>","PeriodicalId":100652,"journal":{"name":"iGIE","volume":"3 4","pages":"Pages 501-506"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143139960","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Obesity is a global health problem, and less-invasive treatments are warranted. We developed a novel endoscopic intervention named peroral endoscopic myo-neurotomy (POEM-N) that is performed at the greater curvature of the gastric antrum as a bariatric/metabolic procedure and assessed its feasibility using porcine models.
Methods
Six live pigs were divided into 3 groups of 2: POEM-N with a high-fat diet (HFD) (POEM-N group); sham procedure with HFD (HF-control group); and sham procedure with normal diet (N-control group). All pigs were fed the diets for 2 weeks, underwent POEM-N or sham procedure, and were observed for 2 weeks after the procedure. The primary outcome was the safety and feasibility of POEM-N. Adverse events and histology of the area after POEM-N were evaluated to assess the procedure’s safety and feasibility. Secondary outcomes were changes in body weight and glycolipid levels.
Results
There was no severe worsening of vital signs during or after the POEM-N procedure. All pigs were well and food intake was good, with no delayed adverse events. Excessive storage of dietary residue, deformity of the gastric antrum, and fold concentration were observed after POEM-N, as expected. Histologic examination revealed hypertrophic regeneration of Auerbach’s plexus, which regulates gastric peristalsis, in both POEM-N pigs. After the procedure, HFD-induced weight gain in the POEM-N pigs slowed, and the increase in serum and liver cholesterol levels was suppressed.
Conclusions
We applied POEM-N as a bariatric/metabolic procedure and showed its safety and feasibility using porcine models.
{"title":"Gastric peroral endoscopic myo-neurotomy as less-invasive bariatric surgery in porcine models: an experimental study","authors":"Kenta Hamada MD, PhD , Yasushi Yamasaki MD, PhD , Akinobu Takaki MD, PhD , Takehiro Tanaka MD, PhD , Hiroyuki Okada MD, PhD","doi":"10.1016/j.igie.2024.06.002","DOIUrl":"10.1016/j.igie.2024.06.002","url":null,"abstract":"<div><h3>Background and Aims</h3><div>Obesity is a global health problem, and less-invasive treatments are warranted. We developed a novel endoscopic intervention named peroral endoscopic myo-neurotomy (POEM-N) that is performed at the greater curvature of the gastric antrum as a bariatric/metabolic procedure and assessed its feasibility using porcine models.</div></div><div><h3>Methods</h3><div>Six live pigs were divided into 3 groups of 2: POEM-N with a high-fat diet (HFD) (POEM-N group); sham procedure with HFD (HF-control group); and sham procedure with normal diet (N-control group). All pigs were fed the diets for 2 weeks, underwent POEM-N or sham procedure, and were observed for 2 weeks after the procedure. The primary outcome was the safety and feasibility of POEM-N. Adverse events and histology of the area after POEM-N were evaluated to assess the procedure’s safety and feasibility. Secondary outcomes were changes in body weight and glycolipid levels.</div></div><div><h3>Results</h3><div>There was no severe worsening of vital signs during or after the POEM-N procedure. All pigs were well and food intake was good, with no delayed adverse events. Excessive storage of dietary residue, deformity of the gastric antrum, and fold concentration were observed after POEM-N, as expected. Histologic examination revealed hypertrophic regeneration of Auerbach’s plexus, which regulates gastric peristalsis, in both POEM-N pigs. After the procedure, HFD-induced weight gain in the POEM-N pigs slowed, and the increase in serum and liver cholesterol levels was suppressed.</div></div><div><h3>Conclusions</h3><div>We applied POEM-N as a bariatric/metabolic procedure and showed its safety and feasibility using porcine models.</div></div>","PeriodicalId":100652,"journal":{"name":"iGIE","volume":"3 3","pages":"Pages 358-365"},"PeriodicalIF":0.0,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142420668","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-09-01DOI: 10.1016/j.igie.2024.07.005
Mike T. Wei MD , Shai Friedland MD
Background and Aims
Endoscopic submucosal dissection (ESD) is increasingly used for resection of benign nonpedunculated colorectal polyps and early cancers. However, there is concern that adoption of ESD may be limited by increased resource utilization with routine postprocedure admission. As endoscopic closure of ESD wounds has improved, in 2022, we adopted an outpatient colorectal ESD protocol.
Methods
This study was a retrospective evaluation of adult patients who underwent colorectal ESD from January 2022 to April 2023. When technically feasible, the wound was closed by clips or suturing. After the procedure, patients were observed for up to 2 hours and discharged if they had no abdominal pain and no intraoperative muscle injury was present. We evaluated for operative success (en-bloc, R0, and curative resection) as well as safety (postprocedure pain, perforation, delayed bleeding).
Results
One hundred eleven lesions were removed by ESD in 105 consecutive patients. Nineteen lesions (17%) had prior EMR. All lesions were successfully removed: The en-bloc resection rate was 93% and the R0 and curative resection rate was 90%. Ninety-nine wounds (89%) were closed, most commonly using clips (60/111; 54%). Two small intraprocedural perforations occurred, both managed with clip closure, and the patients did not require admission. Among patients with defect closure, there were no delayed bleeds requiring hospitalization and only 1 episode of self-limited bleeding. In contrast, among 12 patients with resection sites not amenable to closure, there were 1 delayed bleed requiring hospitalization, 2 minor bleeds assessed at the emergency department, and 2 self-limited bleeds.
Conclusions
In this retrospective study, we demonstrated the feasibility of outpatient colorectal ESD. Among 105 patients, only 2 required hospital admission: 1 for postprocedure pain and 1 for delayed bleeding. We found that after endoscopic closure of ESD wounds, hospital admission was generally unnecessary and significant postprocedure bleeding was rare.
{"title":"Evaluation of the safety and feasibility of outpatient colorectal endoscopic submucosal dissection","authors":"Mike T. Wei MD , Shai Friedland MD","doi":"10.1016/j.igie.2024.07.005","DOIUrl":"10.1016/j.igie.2024.07.005","url":null,"abstract":"<div><h3>Background and Aims</h3><div>Endoscopic submucosal dissection (ESD) is increasingly used for resection of benign nonpedunculated colorectal polyps and early cancers. However, there is concern that adoption of ESD may be limited by increased resource utilization with routine postprocedure admission. As endoscopic closure of ESD wounds has improved, in 2022, we adopted an outpatient colorectal ESD protocol.</div></div><div><h3>Methods</h3><div>This study was a retrospective evaluation of adult patients who underwent colorectal ESD from January 2022 to April 2023. When technically feasible, the wound was closed by clips or suturing. After the procedure, patients were observed for up to 2 hours and discharged if they had no abdominal pain and no intraoperative muscle injury was present. We evaluated for operative success (en-bloc, R0, and curative resection) as well as safety (postprocedure pain, perforation, delayed bleeding).</div></div><div><h3>Results</h3><div>One hundred eleven lesions were removed by ESD in 105 consecutive patients. Nineteen lesions (17%) had prior EMR. All lesions were successfully removed: The en-bloc resection rate was 93% and the R0 and curative resection rate was 90%. Ninety-nine wounds (89%) were closed, most commonly using clips (60/111; 54%). Two small intraprocedural perforations occurred, both managed with clip closure, and the patients did not require admission. Among patients with defect closure, there were no delayed bleeds requiring hospitalization and only 1 episode of self-limited bleeding. In contrast, among 12 patients with resection sites not amenable to closure, there were 1 delayed bleed requiring hospitalization, 2 minor bleeds assessed at the emergency department, and 2 self-limited bleeds.</div></div><div><h3>Conclusions</h3><div>In this retrospective study, we demonstrated the feasibility of outpatient colorectal ESD. Among 105 patients, only 2 required hospital admission: 1 for postprocedure pain and 1 for delayed bleeding. We found that after endoscopic closure of ESD wounds, hospital admission was generally unnecessary and significant postprocedure bleeding was rare.</div></div>","PeriodicalId":100652,"journal":{"name":"iGIE","volume":"3 3","pages":"Pages 413-417"},"PeriodicalIF":0.0,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142420535","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-09-01DOI: 10.1016/j.igie.2024.07.007
Stavros N. Stavropoulos MD, FASGE , Phillip S. Ge MD, FASGE
{"title":"Boldly going where no one has gone before: a history of peroral endoscopic myotomy in the United States","authors":"Stavros N. Stavropoulos MD, FASGE , Phillip S. Ge MD, FASGE","doi":"10.1016/j.igie.2024.07.007","DOIUrl":"10.1016/j.igie.2024.07.007","url":null,"abstract":"","PeriodicalId":100652,"journal":{"name":"iGIE","volume":"3 3","pages":"Pages 424-444"},"PeriodicalIF":0.0,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142420537","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}